Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01879085
Title Phase 1b/2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma
Acronym GemTax
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hussein Tawbi
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field